InvestorBrandNetwork (IBN) Content Platform

QSAM Biosciences (OTCQB: QSAM), a clinical-stage biotechnology company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam), for the treatment of bone cancer and other diseases and conditions, has signed a nonbinding term sheet with Telix Pharmaceuticals (U.S.) Inc., a subsidiary of Telix Pharmaceuticals Limited. Telix is a biopharmaceutical company focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals and associated medical devices. The agreement outlines terms for the acquisition of QSAM by Telix through a merger. Included in the agreement is Telix paying a $2 million preclosing collaboration and option fee to support QSAM’s development efforts while also providing 60 days of exclusivity pending completion of diligence and execution of a definitive acquisition agreement. The acquisition is subject to the satisfactory completion of diligence by both parties, execution of definitive agreements and approval by the QSAM shareholders.

“We are thrilled to commence working with Telix by virtue of the collaboration fee to advance our technology and pursue a definitive agreement leading to the acquisition of QSAM by Telix,” said QSAM executive chair and cofounder Dr. C. Richard Piazza in the press release. “Over the last few months, we have gotten to know Telix’s unique strengths and resources in the radiopharmaceutical space and believe a business combination with them would provide the greatest chances of success for CycloSam(R) and for our shareholders. We will be working diligently to try to get this transaction completed in the first quarter of 2024.”

To view the full press release, visit https://ibn.fm/9HIC4

About QSAM Biosciences Inc.

QSAM Biosciences is developing next-generation nuclear medicines for the treatment of cancer and other diseases. QSAM’s initial technology, CycloSam (Samarium-153 DOTMP), is a clinical-stage, bone-targeting radiopharmaceutical developed by IsoTherapeutics Group LLC, pioneers in the nuclear medicine space that also developed the FDA-approved Quadramet(R) (Samarium-153 EDTMP), which is indicated for bone cancer pain palliation. QSAM is led by an experienced executive team and board of directors that have completed numerous FDA approvals and multiple successful biotech exits. For more information about the company, please visit www.QSAMBio.com

NOTE TO INVESTORS: The latest news and updates relating to QSAM are available in the company’s newsroom at http://ibn.fm/QSAM  

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Tingo Group (NASDAQ: TIO), a profitable, multinational fintech, agri-fintech, food processing and commodity trading company, today announced its financial results for the quarter ended Sept. 30, 2023. Among the highlights, the company reported $2.41 billion in net revenues, $492.5 million in operating profit and $777.9 million in EBITDA for the 9 months ended Sept. 30, 2023. “After a challenging third quarter, where we suffered from the impact of several externally generated factors, I am very pleased with the strong recovery we are seeing in the fourth quarter, which I am confident will see us return to growth,” said Dozy Mmobuosi, co-chief executive officer of Tingo Group and founder of Tingo Mobile and Tingo Foods. “The deepening of our relationship with AFAN, as the umbrella organization for Nigeria’s farmers and agricultural sector, has been a particularly important catalyst in our recovery, as we work with them, together with the cooperatives and several other parties to restore customer confidence following the negative press we received over the summer period in relation to the short seller attack. The adoption of Nwassa as AFAN’s exclusive agricultural marketplace platform, together with AFAN’s commencement to lease and distribute 6 million new smartphones from December, are expected to ensure that Tingo Mobile delivers a strong end to the year.”

To view the full press release, visit https://ibn.fm/zXpYl

About Tingo Group Inc.

Tingo is a global fintech, agri-fintech, food processing and commodity trading group of companies with operations in Africa, Southeast Asia and the Middle East. Tingo Group’s wholly owned subsidiary, Tingo Mobile, is a leading agri-fintech company operating in Africa, with a comprehensive portfolio of innovative products, including a “device-as-a-service” smartphone and a value-added service platform. As part of its globalization strategy, Tingo Mobile has recently begun to expand internationally and entered into trade partnerships that are contracted to increase the number of subscribed farmers from 9.3 million in 2022 to more than 32 million, providing them with access to services including, among others, the Nwassa “seed-to-sale” marketplace platform, insurance, micro-finance, and mobile phone and data top-up. Tingo Group’s other business verticals include: TingoPay, a super app in partnership with Visa, offering a wide range of B2C and B2B services including payment services, an e-wallet, foreign exchange and merchant services; Tingo Foods, a food processing business that processes raw foods into finished products such as rice, groundnut oil, nut products, wheat, millet and maize; and Tingo DMCC, a commodity trading platform and agricultural commodities export business based out of the Dubai Multi Commodities Center. In addition to its Tingo business verticals, Tingo Group also holds and operates an insurance brokerage platform business in China; and Magpie Securities, a regulated finance services fintech business operating out of Hong Kong and Singapore, which, as relatively small businesses within the company, are currently in the process of being reviewed and re-positioned. For more information about the company, visit www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to TIO are available in the company’s newsroom at https://ibn.fm/TIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Predictive Oncology (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence (“AI”) and machine-learning capabilities, extensive biorepository of tumor samples, CLIA laboratory and GMP facility, to accelerate oncologic drug discovery and enable drug development, is reported its financial and operating results for the three- and nine-month periods ending Sept. 30, 2023. Highlights of the report show a net loss of $3.2 million on total net revenue of $0.7 million for the third quarter 2023 along with the successful delivery of actionable results of its first campaign with Cancer Research Horizons (“CRH”), wherein the company predicted with a high degree of accuracy which cancer types and patient populations are most likely to respond to CRH’s preclinical glutaminase inhibitors; the successful completion of a molecular characterization study in collaboration with UPMC Magee-Womens Hospital; and a 22% reduction in net loss in Q3 2023 versus the same quarter in 2022, driven by lower general and administrative expenses. 

“We recently achieved a key milestone with the delivery of successful results from our first campaign with Cancer Research Horizons, a subsidiary of the largest independent funder of cancer research in the world,” said Predictive Oncology CEO and chair Raymond F. Vennare in the press release. “In this groundbreaking and validating work, we leveraged our PEDAL platform and capabilities to evaluate their preclinical glutaminase inhibitors to predict, with a high degree of accuracy, which cancer types and patient populations are most likely to respond to these compounds, providing actionable information that can inform future clinical development pathways. The results from this initial PEDAL campaign further create value by validating the data package for these assets, making them ideal candidates for potential out-licensing. We were also very pleased to announce, just a few days ago, the completion of a molecular characterization study in collaboration with UPMC Magee-Womens Hospital in Pittsburgh to identify the key molecular features that drive overall survival in ovarian cancer. In addition to demonstrating the versatility of our technology, we believe these findings will ultimately contribute to the development of personalized therapies that extend the overall survival of ovarian cancer patients.”

To view the full press release, visit https://ibn.fm/KKops

About Predictive Oncology Inc.

Predictive Oncology is on the cutting edge of the rapidly growing use of artificial intelligence (“AI”) and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy if a tumor sample will respond to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. With the company’s vast biobank of more than 150,000 assay-capable heterogenous human tumor samples, Predictive Oncology offers its academic and industry partners one of the industry’s broadest AI-based, drug-discovery solutions, further complemented by its wholly owned CLIA lab and GMP facilities. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Nemaura Medical (NASDAQ: NMRD), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, is reporting on its financial and business results for the quarter ended Sept. 30, 2023, and providing a business update. Corporate highlights of the report show continued support of its United Kingdom licensee, including efforts to obtain reimbursement for sensors in the area; advanced development of the BEAT diabetes offering; development of NMRD’s consumer metabolic health platform, including possible deployment as a bolt-on service into existing metabolic and wellness programs or to support a direct-to-consumer offering; approval from the Saudi Arabia Food and Drug Agency for marketing of sugarBEAT in the Kingdom of Saudi Arabia (KSA); and continued trials of the company’s prediabetes and consumer metabolic health program with the UK National Health Service. Financial highlights include R&D expenses of $491,803 and $257,061 for the three months ended Sept. 30, 2023 and 2022, respectively; general and administrative expenses totaling $1,558,742 and $1,369,155 for same two periods; net loss coming in at $1,203,454 and $3,855,700 for the three months ended Sept. 30, 2023 and 2022, respectively; and cash and cash equivalents totaling approximately $4.4 million.

In addition, Nemaura Medical launched in the United Kingdom its groundbreaking approach to metabolic health and weight management. The new platform integrates continuous glucose monitoring (“CGM”) with Miboko, its behavioral change program, which complements current pharmaceutical interventions using GLP-1 agonists such as Ozempic, Wegovy and Mounjaro. The new service includes education, lifestyle modifications, dietary guidance, exercise goals, and cutting-edge glucose monitoring. “The launch of this integrated program is a turning point in the company’s history,” said Nemaura CEO Dr Faz Chowdhury in the press release. “Leveraging off positive outcomes observed thus far from the NHS studies and the profound impact of GLP-1 therapy globally leads us to believe we have an optimal offering, with the goal of enabling the drugs to help kick start weight-loss initiatives and then sustain this through education and sustainable behavioral change.” The company is slated to discuss its development tomorrow at 1 p.m. EST during the Sidoti Virtual Investor Conference. Chowdhury is also available for one-on-one meetings with investors.

To view the presentation, visit https://ibn.fm/6FI3E

To view the full press releases, visit https://ibn.fm/T4w8Z and https://ibn.fm/f65wa

About Nemaura Medical Inc.

Nemaura Medical is a medical technology company developing and commercializing noninvasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R) and proBEAT(TM). sugarBEAT, a CE mark-approved class IIb medical device, is a noninvasive and flexible continuous glucose monitor (“CGM”) that provides actionable insights derived from real-time glucose measurements and daily glucose trend data, which may help people with diabetes and prediabetes to better manage, reverse and prevent the onset of diabetes. Nemaura has submitted a proposal for a modular premarket approval application (“PMA”) for sugarBEAT to the U.S. Food and Drug Administration (“FDA”) for its generation II 24-hour sensor. proBEAT is a nonregulated version of sugarBEAT, which combines noninvasive glucose data processed using artificial intelligence and a digital healthcare subscription service as a general wellness product as part of its BEAT diabetes program that is currently undergoing pilot studies. Additionally, Nemaura launched a beta trial of Miboko, a metabolic health and well-being program using a noninvasive glucose sensor along with an AI mobile application that helps a user understand how certain foods and lifestyle habits can impact one’s overall metabolic health and well-being. Nemaura believes that up to half the population could benefit from a sensor and program that monitors metabolic health and well-being. Nemaura sits at the intersection of the global type 2 diabetes market, which is expected to reach nearly $59 billion by 2025, the $50-plus billion prediabetic market and the wearable health-tech sector for weight loss and wellness applications, which is estimated to reach $60 billion by 2023. For more information about the company, visit www.NemauraMedical.com.

NOTE TO INVESTORS: The latest news and updates relating to NMRD are available in the company’s newsroom at https://ibn.fm/NMRD

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Sigma Additive Solutions (NASDAQ: SASI), a provider of quality assurance software to the commercial 3D printing industry, is releasing its financial report and operations update for third quarter 2023, the period ended Sept. 30, 2023. Operations highlights in the report include the signing of a definitive agreement to acquire 100% of the capital stock of NextTrip Holdings in exchange for shares of Sigma common stock, with the acquisition expected to be closed in Q4, 2023, and the signing of a definitive agreement to sell its in-process quality assurance technology suite of assets to Divergent Technologies Inc., which is expected to close after the NextTrip transation. The report also indicated that after these two transactions are finalized, the public company will be a pure play travel technology and booking business that specializes in using proprietary technology, analytics and strategic partnerships to provide specialized travel solutions in leisure, wellness and business travel. Financial results include revenue for the quarter totaling $141,988 compared to revenues of $188,245 for Q3 2023, with gross loss for Q3 2023 totaling $(34,128) and gross margin for the third quarter coming in at (24%). Total operating expenses for the quarter reached $0.9 million, compared to $2.4 million in 2022, a decrease of 64%, with cash total on hand at $0.6 million.

“During the third quarter, we announced our intention to acquire NextTrip Holdings, a travel technology company, as a way to increase shareholder value by providing a significant opportunity to participate in a leading travel brand with an array of product offerings and concierge services,” said Sigma Additive Solutions president and CEO Jacob Brunsberg in the press release. “In October we signed a definitive agreement for the acquisition, and we expect the transactions to be completed in the fourth quarter of 2023, subject to regulatory and shareholder approvals and other customary closing conditions. . . . This transaction will allow NextTrip the ability to execute its growth plans and expand its reach into new markets for the benefit of Sigma equity holders, while tying the issuance of additional equity to clear business objectives for NextTrip. In addition, we signed a definitive agreement to sell our in-process quality-assurance technology suite of assets to Divergent Technologies, a fitting home for our technology. Divergent will build on our foundational work in connection with its DAPS platform, deploying DAPS structures across the automotive, aerospace and defense industries. . . . We are incredibly proud of the opportunity to amplify the growth plans of two impressive companies with these transactions, implying a solid valuation for Sigma and good positioning in public markets for NextTrip, and adding value from the sale of Sigma’s current assets to Divergent.”

To view the full press release, visit https://ibn.fm/TVa8T

About Sigma Additive Solutions

Sigma Additive Solutions is a provider of in-process quality assurance (“IPQA”) solutions to the additive manufacturing industry. Sigma specializes in the development and commercialization of real-time monitoring and analytics known as PrintRite3D(R) for 3D metal and polymer advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real-time during the manufacturing process, enabling significant cost savings and production efficiencies by reducing waste, increasing yield and shortening cycle times. Sigma believes its software solutions may be a major catalyst for the acceleration and adoption of industrial 3D printing. For more information about the company, please visit www.SigmaAdditive.com.

NOTE TO INVESTORS: The latest news and updates relating to SASI are available in the company’s newsroom at http://ibn.fm/SASI

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

RYVYL (NASDAQ: RVYL), a leading innovator of payment-transaction solutions leveraging proprietary blockchain ledger and electronic token technology for the diverse international markets, is reporting financial results for the third quarter ended Sept. 30, 2023. Financial highlights of the report indicate record quarterly revenue for the fourth consecutive quarter, reaching $17.5 million, an increase of 64% year over year, and processing volume of $861 million, an increase of 27% from the second quarter 2023 and above guidance range of $720 to $800 million. The company’s EU business, which included its new banking-as-a-service (“BAAS”) offering, processed $517 million in the third quarter, a 21% increase compared to business volume in Q2, and RYVYL’s North America acquiring business volume was $171 million, 17% higher than the second quarter 2023 volume of $146 million. Corporate highlights include the launch of the coyni mobile point of sale (“mPOS”) app, the appointment of George Oliva as chief financial officer, and the signing of an exchange agreement with the holder of a RYVYL-issued convertible note resulting in a $6 million debt reduction and an increase in cash flow.

“We view banking-as-a-service as the future of global banking and are excited to be an enabling service provider in a space that is rapidly emerging and reaching new customers every day,” said RYVYL CEO Fredi Nisan in the press release. “Being a Visa Direct partner has allowed us to leverage their capabilities and provide a superior banking as a service offering. We are working tirelessly on this initiative, which will enable us to better serve our customers, retain their loyalty and create new revenue streams. By mid-year 2024, we expect RYVYL, along with its subsidiaries and other affiliates, to have a full global payments platform covering over one hundred local currencies with authorized accounts in the markets we operate in. . . . Looking ahead, we believe that we are well positioned to close out 2023 on a strong note and are projecting Q4 revenues to be in the range of $19 to $21 million on processing volume of $900 million to $1 billion. With steady growth in our core processing business and the ongoing implementation of key strategic growth initiatives with coyni and banking-as-a-service progressing, we believe that we are in the best position we have ever been to generate long-term sustainable value for our shareholders.”

To view the full press release, visit https://ibn.fm/zSuLr

About RYVYL

RYVYL was born from a passion for empowering a new way to conduct business-to-business, consumer-to-business, and peer-to-peer payment transactions around the globe. By leveraging proprietary blockchain ledger and electronic token technology for the diverse international markets, RYVYL is a leading innovator of payment transaction solutions reinventing the future of financial transactions. Since its founding as GreenBox POS in 2017, RYVYL has developed applications enabling an end-to-end suite of turnkey financial products with enhanced security and data privacy, world-class identity theft protection, and rapid speed to settlement. As a result, the platform can log immense volumes of immutable transactional records at the speed of the internet for first-tier partners, merchants and consumers around the globe. For more information about the company, please visit www.RYVYL.com.

NOTE TO INVESTORS: The latest news and updates relating to RVYL are available in the company’s newsroom at https://ibn.fm/RVYL

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, announced that Virgil Thompson passed away unexpectedly on Nov. 9, 2023. Thompson, 83 years old, had served on PCSA’s board of directors since the company was formed in 2017 and before that served on the board of directors at Promet Therapeutics LLC, PCSA’s predecessor. Over his career Thompson’s experiences included serving as an executive and/or director for several biotechnology companies. “We are all saddened by the sudden passing of our friend and one of our founding board members, Virgil Thompson,” said Processa Pharmaceuticals board chair Justin Yorke in the press release. “We are thankful for Virgil’s leadership, guidance and wisdom, and we will remember him fondly. He will be greatly missed by the board and the whole Processa family.”

To view the full press release, visit https://ibn.fm/yRK7E

About Processa Pharmaceuticals Inc.

Processa is a clinical-stage pharmaceutical company focused on developing next-generation chemotherapy (“NGC”) drugs to improve the safety and efficacy of cancer treatment. By combining Processa’s novel oncology pipeline with proven cancer-killing active molecules and the Processa Regulatory Science Approach as well as experience in defining optimal dosage regimens for FDA approvals, Processa not only will be providing better therapy options to cancer patients but also will increase the probability of FDA approval for its next-generation chemotherapy drugs. Processa’s NGC drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells. The company’s approach to drug development is based on more than 30 years of drug-development expertise to efficiently design and conduct clinical trials that demonstrate a positive benefit/risk relationship. Using its proven Regulatory Science Approach, the company has experience defining the optimal dosage regimen using the principles of the FDA’s Project Optimus Oncology initiative. The advantages of Processa’s NGC drugs are expected to include fewer patients experiencing side effects that lead to dose discontinuation; more significant cancer response; and a greater number of patients who will benefit from each NGC drug. Currently in the company pipeline are three NGC drugs: Next Generation Capecitabine (PCS6422 and capecitabine to treat metastatic colorectal, gastrointestinal, breast, pancreatic and other cancers), Next Generation Gemcitabine (PCS3117 to treat pancreatic, lung, ovarian, breast and other cancers), and Next Generation Irinotecan (PCS11T to treat lung, colorectal, gastrointestinal, pancreatic and other cancers). For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

PowerTap (NEO: MOVE) (OTC: MOTNF) (FWB: 2K6) recently provided an update on the status of a management cease trade order granted on Sept. 29, 2023, (the “MCTO”) by the British Columbia Securities Commission under National Policy 12-203 – Management Cease Trade Order (“NP 12-203”). The company announced, on Sept. 29, 2023, that, for reasons disclosed in the news release, there would be a delay in the filing of its financial statements and accompanying management’s discussion and analysis for the fiscal year ended June 30, 2023 (the “annual filings”) beyond the period prescribed under applicable Canadian securities laws. During the MCTO, the general investing public will continue to be able to trade in PowerTap’s listed common shares. However, the company’s CEO and CFO will not be able to trade in its common shares. Further to the status update made on Oct. 27, 2023, the company advised that it continues to search for a successor auditor to be appointed following the resignation of SHIM & Associates LLP and will provide a further update in due course.

To view the full press release, visit https://ibn.fm/JjXyF

About PowerTap Hydrogen Capital Corp.

PowerTap Hydrogen Capital Corp., through its wholly owned subsidiary, PowerTap Hydrogen Fueling Corp. (“PowerTap”), is focused on installing hydrogen production and dispensing fueling infrastructure in the United States. PowerTap’s patented solution has been developed over 20 years. PowerTap is now commercializing its third-generation blue hydrogen product that will focus on the refueling needs of the automotive and long-haul trucking markets that lack hydrogen fueling infrastructure. For more information about the company, visit www.PowerTapcapital.com.

NOTE TO INVESTORS: The latest news and updates relating to MOTNF are available in the company’s newsroom at https://ibn.fm/MOTNF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Gratomic (TSX.V: GRAT) (OTCQX: CBULF) (FSE: CB82), a multinational company with projects in Namibia, Brazil and Canada, has updated its commercial partnership and sales agreement with TM2 Verticals. The agreement outlines the company’s commitment to supply purified flake graphite (“PFG”) to the alkaline battery sector. According to the announcement, TM2 Verticals has partnered with Gratomic and Suntech Labs of South Africa to successfully upgrade Aukam graphite concentrate to the required 96% grade concentrate as part of a large-scale pilot plant OEM qualification program designed to generate bulk samples that can be sent to alkaline battery producers around the world. The collaboration marks an “important milestone” in the global alkaline battery market opportunity for Gratomic. Over the next 36 months, every major OEM on the planet will be backwards integrating, noted TM2 officials, who observed that securing long-term supply and a reliable supply chain remains on target and a key catalyst for ongoing successful operations. The alkaline battery market is projected to reach an estimated annual sales of more than $8 billion, requiring more than 14,000 tons of graphite material. “The partnership with TM2 is steadily advancing towards our common objectives of being ahead of competition in one of the most dynamic high value applications for graphite,” said Gratomic CEO and president Arno Brand in the press release.

To view the full press release, visit https://ibn.fm/5ojur

About Gratomic Inc.  

Gratomic is a multinational company with projects in Namibia, Brazil and Canada. The company is focused on becoming a leading global graphite supplier and aims to secure a strong position in the electric vehicle (“EV”) battery supply chain. With the continued development of its flagship Aukam Project and further exploration on its Capim Grosso property, Gratomic sets itself apart by seeking out unique top-quality assets around the world. True to its roots, the company will continue to explore graphite opportunities displaying potential for development. Large quantities of high-quality vein graphite have been shipped for testing to confirm its viability as an anode material. Gratomic is confident that the test results will provide a unique competitive advantage in its desired target markets. The company will continue to update the public on the status of these tests and will provide results as soon as they become available. The company has also formed a collaboration agreement with Forge Nano. This cooperation is a key element in supporting Gratomic’s strategies toward the value-added phases of producing graphite for anode applications, namely micronization, spheronization and coating, making Gratomic graphite a preferred choice for use in lithium-ion batteries. For more information about the company, visit www.Gratomic.ca.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

DarioHealth (NASDAQ: DRIO), a leader in the global digital health market, is reporting on new research presented last week at the Diabetes Technology Society 2023 Meeting. According to the announcement, the new study demonstrates the value of associating physical activity tracking alongside blood sugar tracking for people living with diabetes and prediabetes; the results emphasize the value of a whole-health approach managing chronic conditions as well as supporting those using GLP-1s, or anti-obesity medication. Specifically, the study evaluated the blood glucose and walking data of 989 Dario users in an effort to explore and understand the impact of integrating clinical and behavioral data in a single digital app-based experience. The results showed significantly reduced blood glucose levels in the first four months that participants used Dario as well as increased step levels in the same timeframe; those results were maintained for 12 months. The research was conducted in partnership with the Integrative Pain Laboratory at the School of Public Health at the University of Haifa. “Improving health behaviors is the key to improving outcomes, and Dario is intensely focused on the intersection of those behaviors with clinical intelligence gained from more than a decade of consumer engagement,” said Dario chief medical officer Omar Manejwala, MD, in the press release. “We are excited to see this new study shed light on the impact a singular focus on whole health can have for our members and our partners.”

To view the full press release, visit https://ibn.fm/RltGa

About DarioHealth Corp.

DarioHealth Corp. is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition digital therapeutics platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results, and making the right thing to do the easy thing to do. Dario provides its highly user-rated solutions globally to health plans and other payors, self-insured employers and providers of care as well as directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Uranium Energy (NYSE American: UEC) today announced that it has filed an Initial Assessment Technical Report Summary (“TRS”) in accordance with Item 1302 of Regulation S-K (“S-K 1300”) on EDGAR disclosing mineral resources and an economic assessment for the company’s 100% owned Alto Paraná Titanium Project located in Paraguay. Among the highlights, the company reported a combined regional resource of 3.6 billion tonnes, grading at 7.3% TiO 2, for the Alto Paraná Titanium Project. “UEC is a uranium focused company and through our presence and uranium exploration activities in Paraguay since 2012, we identified a unique opportunity to acquire the world-class Alto Paraná Titanium Project in 2017 for a nominal investment,” said Amir Adnani, UEC president and CEO. “We are delighted to present an initial economic evaluation of the project that provides a pathway forward in unlocking its substantial value. The study confirms Alto Paraná as one of the highest grade and largest known ilmenite deposits on the globe with compelling economics.”

To view the full press release, visit https://ibn.fm/XaIho

About Uranium Energy Corp.

Uranium Energy is the fastest growing supplier of the fuel for the green energy transition to a low carbon future. UEC is the largest, diversified North American focused uranium company, advancing the next generation of low-cost, environmentally friendly ISR mining uranium projects in the United States and high-grade conventional projects in Canada. The company has two production-ready ISR hub-and-spoke platforms in South Texas and Wyoming. These two production platforms are anchored by fully operational central processing plants and served by seven U.S. ISR uranium projects with all their major permits in place. Additionally, the company has diversified uranium holdings including: (1) one of the largest physical uranium portfolios of U.S. warehoused U3O8; (2) a major equity stake in Uranium Royalty Corp., the only royalty company in the sector; and (3) a Western Hemisphere pipeline of resource stage uranium projects. The company’s operations are managed by professionals with decades of hands-on experience in the key facets of uranium exploration, development and mining.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Tingo Group (NASDAQ: TIO), a profitable, multinational fintech, agri-fintech, food processing and commodity trading company, today announced a change of personnel in connection with the role of group chief financial officer. Amir Ayalon, who accepted the position on Oct. 2, 2023, has moved into a part-time consultancy role due to a significant change in his personal circumstances. Kevin Chen, Tingo’s prior chief financial officer, who currently serves as the CFO for the company’s operations in Asia, has agreed to resume his duties as group CFO on an interim basis, pending his formal appointment by the company’s board of directors later this week. “We regret, but fully understand, the personal circumstances under which we have received the resignation of Amir Ayalon as our chief financial officer,” said Ken Denos, interim chief executive officer of Tingo Group. “Amir made an impressive start towards serving the company during his short tenure, and we look forward to his continued service in a part-time role to assist the company in strengthening its finance and reporting functions as a world class agri-fintech and food processing company. We are fortunate to have our previous CFO, Kevin Chen, ready to serve in an interim capacity while we secure a permanent industry-experienced executive to lead our finance and accounting team.”

The company also announced that its trade partner, the All Farmers Association of Nigeria (“AFAN”), has formally adopted Tingo Mobile’s Nwassa as its exclusive marketplace platform for its members. “Our partnership with AFAN continues to go from strength-to-strength, and AFAN’s exclusive adoption of Nwassa as the recommended marketplace platform for their farmers is both a significant and humbling endorsement,” said Dozy Mmobuosi, interim co-chief executive officer of Tingo Group. “I am extremely grateful to AFAN’s president, Farouk Rabiu Mudi, and AFAN’s National Executive Council, for their tremendous support as we work closely with AFAN to further improve and expand Nigeria’s agricultural sector and deliver empowerment and financial upliftment to Nigeria’s farmers.”

To view the full press releases, visit https://ibn.fm/DtWtg and https://ibn.fm/ucmHG

About Tingo Group Inc.

Tingo is a global fintech, agri-fintech, food processing and commodity trading group of companies with operations in Africa, Southeast Asia and the Middle East. Tingo Group’s wholly owned subsidiary, Tingo Mobile, is a leading agri-fintech company operating in Africa, with a comprehensive portfolio of innovative products, including a “device-as-a-service” smartphone and a value-added service platform. As part of its globalization strategy, Tingo Mobile has recently begun to expand internationally and entered into trade partnerships that are contracted to increase the number of subscribed farmers from 9.3 million in 2022 to more than 32 million, providing them with access to services including, among others, the Nwassa “seed-to-sale” marketplace platform, insurance, micro-finance, and mobile phone and data top-up. Tingo Group’s other business verticals include: TingoPay, a super app in partnership with Visa, offering a wide range of B2C and B2B services including payment services, an e-wallet, foreign exchange and merchant services; Tingo Foods, a food processing business that processes raw foods into finished products such as rice, groundnut oil, nut products, wheat, millet and maize; and Tingo DMCC, a commodity trading platform and agricultural commodities export business based out of the Dubai Multi Commodities Center. In addition to its Tingo business verticals, Tingo Group also holds and operates an insurance brokerage platform business in China; and Magpie Securities, a regulated finance services fintech business operating out of Hong Kong and Singapore, which, as relatively small businesses within the company, are currently in the process of being reviewed and re-positioned. For more information about the company, visit www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to TIO are available in the company’s newsroom at https://ibn.fm/TIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading U.S.-based critical minerals company, has sold the remaining unpaid balance of $20 million owed under a secured convertible note to MMCAP International Inc. SPC. The note was issued to Energy Fuels by enCore Energy Corp. as partial consideration for enCore’s purchase of the Alta Mesa In-Situ Recovery Project. According to the announcement, enCore previously paid $40 million toward the $60 million principal note balance and $1.8 million of interest to the company in partial fulfillment of the note obligations. With enCore’s earlier paydown and the $22.4 million received in connection with the sale of the note, Energy Fuels has now received payment in full for the Alta Mesa sale, with no further amount being owed.

To view the full press release, visit https://ibn.fm/7rg1O

About Energy Fuels Inc.

Energy Fuels is a leading U.S.-based critical minerals company. As the leading producer of uranium in the United States, Energy Fuels mines uranium and produces natural uranium concentrates that are sold to major nuclear utilities for the production of carbon-free nuclear energy. Energy Fuels recently began production of advanced rare earth element (“REE”) materials, including mixed REE carbonate, and plans to produce commercial quantities of separated REE oxides in the future. Energy Fuels also produces vanadium from certain of its projects, as market conditions warrant, and is evaluating the recovery of radionuclides needed for emerging cancer treatments. Its corporate offices are in Lakewood, Colorado, and substantially all assets and employees are in the United States. Energy Fuels holds two of America’s key uranium production centers: the White Mesa Mill in Utah and the Nichols Ranch in-situ recovery (“ISR”) project in Wyoming. The White Mesa Mill is the only conventional uranium mill operating in the country today, has a licensed capacity of more than 8 million pounds of U3O8per year, and has the ability to produce vanadium when market conditions warrant, as well as REE products, from various uranium-bearing ores. The Nichols Ranch ISR project is on standby and has a licensed capacity of 2 million pounds of U3O8per year. The company recently acquired the Bahia Project in Brazil, which is believed to have significant quantities of titanium (ilmenite and rutile), zirconium (zircon) and REE (monazite) minerals. In addition, Energy Fuels also has one of the largest NI 43-101-compliant uranium resource portfolios in the United States and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

IGC Pharma (NYSE American: IGC) is reporting financial and business results for second quarter 2023, the period ending Sept. 30, 2022. Highlights of the report include revenue in second quarter FY2024 increasing 44%, totaling an estimated $291,000 compared to the same quarter in FY2023, which was reported at approximately $202,000, with revenue in the first six months of fiscal year 2024 doubling to some $846,000, compared to $414,000 from the same six-month period last year. The report noted that IGC revenue primarily comes from its over-the-counter products and services available at its Vancouver, Washington, facility, which is being prepared for a potential phase 3 trial and commercialization of the company’s investigational new drug: IGC-AD1. The report also noted that IGC-AD1, which is in trials to address agitation in dementia due to Alzheimer’s, continues to make progress in its multisite phase 2 trial, which includes 10 test sites throughout the United States and Canada.

In addition, this quarter saw the company receive a patent from the Canadian Intellectual Property Office related to compositions and methods for treating multiple types of seizure disorders in humans using a combination of cannabinoids with other compounds. “We continue to make strides advancing our numerous drug formulations, with our flagship asset, IGC-AD1, currently in phase 2 trials for the treatment of agitation caused by symptoms of Alzheimer’s disease,” said IGC Pharma CEO Ram Mukunda in the press release. “Including IGC-AD1, we have five drug assets — TGR-63, LMP, IGC-1C, and IGC-M3 — all of which have shown preclinical efficacy in targeting Alzheimer’s disease. They are at various stages of development. In addition to our traditional trial methods, we are also exploring the capabilities of generative artificial intelligence, or AI, as it relates to analyzing the myriad of data produced by a trial and maximizing the efficiency and minimizing the time needed to conduct clinical trials. For this, we entered a master cooperation agreement with a leading university in Colombia, South America, with expertise in AI and pharma. We are pleased with the progress that we’ve made this quarter, and we believe that we are well positioned with strategic partnerships and a clear path to bring solutions to market for the treatment of Alzheimer’s.”

To view the full press release, visit https://ibn.fm/kMIZX

About IGC Pharma

IGC Pharma is pioneering innovative solutions to combat Alzheimer’s disease and related challenges. The company’s portfolio comprises five assets, each at distinct stages of development and all with a singular mission: to transform the landscape of Alzheimer’s treatment. IGC-AD1 and LMP targets neuroinflammation, Aβ plaques and neurofibrillary tangles; IGC-AD1 is currently in a phase 2b clinical trial for agitation in dementia due to Alzheimer’s, representing a critical step in the company’s journey to deliver impactful therapies. TGR-63 targets Aβ plaque, where IGC Pharma seeks to disrupt the progression of Alzheimer’s disease. IGC-M3 targets both Aβ plaques and tau, two Alzheimer’s defining hallmarks, with the potential to create a profound impact. IGC-1C targets tau and neurofibrillary tangles, and IGC-1C represents a forward-thinking approach to Alzheimer’s therapy. IGC Pharma is at the forefront of generative AI development, with projects spanning clinical trials, molecule discovery and analysis, and drug interactions. For more information, visit the company’s website at www.IGCInc.us.

NOTE TO INVESTORS: The latest news and updates relating to IGC are available in the company’s newsroom at https://ibn.fm/IGC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Siyata Mobile (NASDAQ: SYTA), a global developer and vendor of push-to-talk over cellular (“PoC”) handsets and accessories, today announced that it will host a conference call at 8:30 a.m. ET on Thursday, Nov. 16 to discuss its third quarter 2023 financial results. Interested parties should visit https://ibn.fm/EYzFz to register for the event and dial +1 (877) 545-0523 (North America) or +1 (973) 528-0016 (international) and enter access code 503806 to join the call. A replay will be available until Nov. 30, 2023, by dialing +1 (877) 481-4010 or +1 (919) 882-2331 and entering passcode 49473.

To view the full press release, visit https://ibn.fm/LGZUB

About Siyata Mobile Inc.

Siyata Mobile is a B2B global developer and vendor of next-generation push-to-talk (“PTT”) over cellular handsets and accessories. Its portfolio of rugged PTT handsets and accessories enables first responders and enterprise workers to instantly communicate over a nationwide cellular network of choice to increase situational awareness and save lives. Police, fire and ambulance organizations as well as schools, utilities, security companies, hospitals, waste management companies, resorts and many other organizations use Siyata PTT handsets and accessories today. In support of its PTT handsets and accessories, Siyata also offers enterprise-grade in-vehicle solutions and cellular booster systems enabling its customers to communicate effectively when they are in their vehicles, and even in areas where the cellular signal is weak. Siyata sells its portfolio through leading North American cellular carriers and through international cellular carriers and distributors. Siyata’s common shares and its previously issued warrants trade on the Nasdaq under the symbols SYTA and SYTAW, respectively. Visit SiyataMobile.com and UnidenCellular.com to learn more.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at https://ibn.fm/SYTA

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

• Arizona-based SenesTech Inc. provides a unique approach to rodent pest control by formulating a contraceptive that works as birth control in both male and female rats
• A major milestone has been reached by the company as it recently began taking orders for its new Evolve(TM) Soft Bait formulation, which joins SenesTech’s liquid ContraPest(R) brand as a population-control solution that avoids some of the problems associated with lethal rodenticides
• The Evolve(TM) Soft Bait product is targeting the vast professional pest control market that prefers a non-liquid product, as well as providing a consumer-friendly option that may be marketed through big box retailers and e-commerce providers
• SenesTech’s operation has been growing rapidly this year, and company officers stated last month that its “pro forma cash balance” is $4 million with no long-term debt

With the advent of cooler weather in the Northern Hemisphere, rodents become more noticeable in homes and buildings as they seek warmer refuge. Pest control giant Orkin estimates mice and other rodents invade around 21 million homes across the United States each fall, according to its annual report on the “50 rattiest cities” (https://ibn.fm/0X9O6).

Rodent control innovator SenesTech (NASDAQ: SNES) is using its own unique approach to the science of reducing rat populations to help clients and pest control companies enjoy the holiday season without such unwanted guests. They have developed a means of birth control for the rodents that keeps their…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Mountain Top Properties (OTC: MTPP) specializes in property management, property technology (“PropTech”) and real estate redevelopment. “The company’s flagship subsidiary is Mountain Top Realty Inc., the managing partner of its first real estate fund focused on residential redevelopment in the prestigious and storied Hamptons, New York, beachfront communities. Mountain Top Properties is also the lead investor in blockchain-enabled industrial and warehouse flex space HQXpress, which services the warehousing, reverse logistics and liquidation markets. The company is in negotiations for the addition of AI-powered technologies that promise to simplify real estate services, including purchasing and sales,” a recent article reads. “Mountain Top Capital Fund I LLC is a New York limited liability company recently organized by affiliates of Mountain Top Realty, manager of the fund. Through this fund, Mountain Top Realty will leverage the company’s experience, market conditions and industry relationships to capitalize on real estate projects as they arise. This partnership will be focused on waterfront or water view properties in the Hamptons. The Hamptons market has historically remained strong and continues to set new highs year over year.”

To view the full article, visit https://ibn.fm/mciPY

About Mountain Top Properties Inc.

Mountain Top Properties is a diversified real estate holding company that acquires, sells and operates assets through its wholly owned subsidiaries and limited partnerships. The company specializes in property management, property technology (“PropTech”) and real estate redevelopment.

NOTE TO INVESTORS: The latest news and updates relating to MTPP are available in the company’s newsroom at https://ibn.fm/MTPP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

IBN (“InvestorBrandNetwork”), a leading corporate communications firm and content distributor, today announced its collaboration with ROTH MKM (“ROTH”) for the upcoming 3rd Annual AgTech Answers Conference. The highly anticipated event is slated to take place at The Yale Club in New York City on Nov. 14, 2023. The conference will provide exceptional networking opportunities for senior leadership from analyst-selected companies and seasoned institutional investors and shine the spotlight into the ever-evolving landscape of the agriculture technology (“AgTech”) industry. As the official media sponsor, IBN will leverage its state-of-the-art corporate communication solutions to enhance the visibility of the conference and drive increased viewership with its extensive network and a wide array of premium digital channels. As an integral part of IBN’s robust Dynamic Brand Portfolio (‘DBP’), InvestorWire will play a pivotal role in disseminating content across a wide range of global news outlets.

To view the full press release, visit https://ibn.fm/jeWgl

About IBN

IBN consists of financial brands introduced to the investment public over the course of 17+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Through our Dynamic Brand Portfolio (‘DBP’), IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) Press Release Enhancement to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) total news coverage solutions.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, is expanding its services in New York and has inked a deal for the sale of 15 machines to a California police department.

According to the company, Port Authority New York New Jersey has signed a contract for the Knightscope Emergency Management System (“KEMS”) Professional service. The agency will use the system to monitor its 11 K1 Call Boxes that are located on the George Washington Bridge, which spans the Hudson River and connects New Jersey to New York.

“The KEMS platform allows clients and technicians to better understand the real-time health and status of deployed emergency communication devices,” stated the company in the press release. “The cloud-based application monitors the system wide state-of-health, alerts users concerning operational issues, provides technicians real-time error detection/diagnostics, and collects/reports system performance statistics.”

In addition, a police department in Southern California entered a contract to purchase five K1 Blue Light Towers and 10 K1 Blue Lighe E-phones. The towers are slated for installation in a new public park while the K1 Blue Light E-Phones will be located in a new parking structure.

“Knightscope’s Blue Light Towers, E-Phones and Call Boxes expand access to emergency communications for motorists, bicyclists and pedestrians utilizing the bridge as well as the park visitors by providing direct access to emergency services for people who may be experiencing danger, a crisis or some form of distress,” the company stated in the press release.

To view the full press release, visit https://ibn.fm/V5VMp

About Knightscope, Inc.

Knightscope is an advanced public safety technology company that builds fully autonomous security robots and blue light emergency communications systems that help protect the places people live, work, study and visit. Knightscope’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Cybin (NYSE American: CYBN) (NEO: CYBN) is a clinical-stage biopharmaceutical company committed to revolutionizing mental health care by developing new and innovative next-generation psychedelic treatment options. The company today announced a firm commitment underwritten offering of 66,666,667 units of CYBN to one of its largest existing institutional shareholders and new institutional investors at a price of US$0.45 per unit for gross proceeds of approximately US$30 million. According to the announcement, approximately US$30 million will be funded in full upon the closing of the offering, and up to an additional US$34 million may be funded upon full exercise of the warrants. A.G.P./Alliance Global Partners is acting as the sole book-running manager for the offering, which is expected to close on or about Nov. 15, 2023.

To view the full press release, visit https://ibn.fm/4iKLA

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. Cybin’s goal of revolutionizing mental health care is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and treatment regimens. The company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland.

NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Standard Lithium (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L), a leading near-commercial lithium company, has announced its financial and operating results for the fiscal first quarter 2024 ended Sept. 30, 2023. “This quarter has marked a pivotal advancement in our journey towards establishing a new benchmark for scalable and sustainable lithium production in the United States. The completion of our Phase 1A Definitive Feasibility Study (‘DFS’) is a key milestone, advancing our planned first commercial lithium project which is a modest scale-up from our operating Direct Lithium Extraction demonstration plant. The Preliminary Feasibility Study (‘PFS’) for our South West Arkansas (‘SWA’) Project has identified the potential for a considerably larger-scale operation with a lithium grade that significantly enhances our resource profile and potential production capacity increasing the overall strategic value of our business,” said Robert Mintak, CEO of Standard Lithium. “Our highly strategic expansion in East Texas over the last three years has given us a significant head start in establishing a sizeable foothold in the region.”

To view the full press release, visit https://ibn.fm/2fj6u

About Standard Lithium Ltd.

Standard Lithium is a leading near-commercial lithium development company focused on the sustainable development of a portfolio of lithium-brine bearing properties in the United States. The company prioritizes brine projects characterized by high-grade resources, robust infrastructure, skilled labor, and streamlined permitting. The company aims to achieve sustainable, commercial-scale lithium production via the application of a scalable and fully integrated direct lithium extraction (“DLE”) and purification process. The company’s signature projects, the Phase 1A and the South West Arkansas projects, are located on the Smackover Formation in southern Arkansas near the Louisiana state line, a region with a long-standing and established brine processing industry. The company has also identified a number of highly prospective lithium brine project areas in the Smackover Formation in East Texas and began an extensive brine leasing program in the key project areas. In addition, the company has an interest in certain mineral leases located in the Mojave Desert in San Bernardino County, California. Standard Lithium trades on both the TSX Venture Exchange and the NYSE American under the symbol SLI and on the Frankfurt Stock Exchange under the symbol S5L. For more information, please visit the company’s website at www.StandardLithium.com.

NOTE TO INVESTORS: The latest news and updates relating to SLI are available in the company’s newsroom at https://ibn.fm/SLI

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Exro Technologies (TSX: EXRO) (OTCQB: EXROF) is a leading clean technology company that has developed new generation power control electronics that expand the capabilities of electric motors and batteries. The company announced its financial results for the quarter ended Sept. 30, 2023. Among the highlights, Exro reported that it generated revenue of $2,032,669 for the three months ended Sept. 30, 2023, and $4,800,730 for the nine months ended Sept. 30, 2023. Key operational highlights included Exro’s official start of production of the company’s Coil Driver(TM) technology, which it announced on Sept. 6, and the achievement of certification of its Cell Driver(TM) battery modules to the UL 1973 standard, which it announced on Aug. 22, along with the recent grant of patent #US11,708,005 B2, “Systems and Methods for Individual Control of a Plurality of Battery Cells,” for its Cell Driver(TM).

To view the full press release, visit https://ibn.fm/XXPFb

About Exro Technologies Inc.

Exro Technologies is a leading clean technology company that has developed new generation power control electronics that change how the world optimizes energy by expanding the capabilities of electric motors and batteries. The company’s innovative technologies serve to bridge the performance-cost gap in e-mobility (Coil Driver(TM)) and stationary energy storage (Cell Driver(TM)), and act to accelerate adoption towards a circular electrified economy by delivering more with less – minimum energy for maximum results. For more information, visit the company’s website at www.Exro.com.

NOTE TO INVESTORS: The latest news and updates relating to EXROF are available in the company’s newsroom at http://ibn.fm/EXROF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Vistagen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, is reporting its second-quarter 2024 results for the period ended Sept. 30, 2023. Highlights of the report include that fasedienol (“PH94B”), the company’s PALISADE phase 3 program for acute treatment of social anxiety disorder (“SAD”), is advancing to build on recent positive PALISADE-2 phase 3 results with preparations for possible phase 3 studies to begin in 2024; that itruvone (“PH10”) is ) is being staged for potential phase 2B clinical development 2024; and that PH80 positive exploratory phase 2A trial data reported in two separate women’s health indications, including vasomotor symptoms (hot flashes) due to menopause and premenstrual dysphoric disorder (“PMDD”).

Financial results for the quarter show the company saw $137.7 million in gross proceeds secured since the beginning of fiscal 2024 second quarter, including $100 million from an underwritten public offering of equity securities; the report also noted that Vistagen Therapeutics has an adequate cash runway for a potential U.S. New Drug Application based on fasedienol as an acute treatment of SAD. “Vistagen achieved multiple important milestones in recent months, significantly advancing our innovative pipeline, including positive phase 3 results for fasedienol, our lead pherine nasal spray drug candidate,” said Vistagen CEO Shawn Singh in the press release. “With a fortified balance sheet, a robust pipeline of drug candidates differentiated from the current standards of care, and a clear path forward in our potential U.S. New Drug Application-enabling PALISADE phase 3 program for fasedienol in social anxiety disorder, we are confident in our potential to improve the lives of millions of individuals affected by SAD and other large market mental health and CNS disorders.”

To view the full press release, visit https://ibn.fm/yqQjH

About Vistagen Therapeutics Inc.

Vistagen Therapeutics is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster acting and with fewer side effects and safety concerns than treatments that are currently available for treatment of anxiety, depression and multiple CNS disorders. Vistagen is advancing therapeutics with the potential to be faster-acting, and with fewer side effects and safety concerns, than those currently available for the treatment of anxiety, depression, and multiple CNS disorders. Vistagen’s pipeline includes six clinical-stage product candidates, including fasedienol (“PH94B”), itruvone (“PH10”), PH15, PH80 and PH284, each an investigational agent belonging to a new class of drugs known as pherines, as well as AV-101, which is an oral prodrug antagonist of the N-methyl-D-aspartate receptor (“NMDAR”). Pherines are neuroactive nasal sprays designed with an innovative and differentiated proposed mechanism of action (“MOA”) that activates chemosensory neurons in the nasal cavity and can beneficially impact key neural circuits in the brain without systemic absorption or direct activity on neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety, depression and several other CNS disorders. For more information about the company, please visit www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

OneMedNet (NASDAQ: ONMD, ONMDW), the leading curator of regulatory-grade Imaging Real World Data (“iRWD”) through its proven OneMedNet iRWD(TM) solution, has completed its previously announced business combination with Data Knights Acquisition Corp. As a result, the company’s common stock began trading on NASDAQ under the ticker ONMD earlier this week. According to the announcement, the business combination was approved during a special meeting of Data Knights stockholders. The company offers innovation solutions that connect healthcare providers and patients, offering direct access to clinical images and associated contextual patient record. “Reaching this milestone represents a strong step forward for OneMedNet,” said OneMedNet CEO Paul Casey in the press release.

“The finalization of the merger with Data Knights is a direct testament to the diligence and hard work of the collective teams and the continued acknowledgement of OneMedNet’s unique and innovative regulatory grade iRWD data solution, which supplies the life sciences industry with an actionable component to earlier detection and monitoring in the discovery of therapeutics and treatments. The company has made significant strides in product and innovation capabilities and formed a solid operating structure required to effectively accelerate our growth strategy, including expanding our network through our active pipeline of partnership opportunities, and expanding OneMedNet’s team to include leading industry talent. The $400 billion market of clinical research and clinical trials is a minimally penetrated greenfield opportunity for the Company and serves as a sustainable and ongoing competitive advantage to accelerate our growth and ultimately unlock value for all of our stakeholders.”

To view the full press release, visit https://ibn.fm/ovKeN

About OneMedNet Corporation

Founded in 2009, OneMedNet provides innovative solutions that unlock the significant value contained within the clinical image archives of healthcare providers. Employing its proven OneMedNet iRWD solution, OneMedNet securely deidentifies, searches and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with industry leading technology and in-house clinical expertise, OneMedNet successfully meets the most rigorous RWD Life Science requirements. For more information about the company, please visit www.OneMedNet.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Noble Capital Markets, Inc. (“Noble”) today announced that Seeking Alpha, the world’s leading investing community, will be a prominent sponsor at NobleCon19, Noble’s 19th Annual Emerging Growth Equity Conference. The event is slated to take place Dec. 3-5, 2023, at Florida Atlantic University, College of Business, Executive Education, in Boca Raton, Florida. NobleCon19 will feature 200 public company executives, corporate presentations, breakouts, one-on-one meetings with qualified attendees, provocative panels, and a keynote fireside chat featuring the 43rd President of the United States, George W. Bush, moderated by Noble’s Director of Research, Michael Kupinski. As a sponsor, Seeking Alpha will play a significant role in enhancing the conference experience for attendees.

“We are thrilled to have Seeking Alpha on board as a sponsor for NobleCon19,” said Nico P. Pronk, CEO of Noble Capital Markets, the host of NobleCon19. “Their research and analysis tools and resources for the investment community align perfectly with the objectives of our conference. We believe their involvement will enhance the overall event, providing attendees with valuable perspectives and knowledge.”

To view the full press release, visit https://ibn.fm/hJmmT

About Noble Capital Markets Inc.

Noble Capital Markets was incorporated in 1984 as a full-service SEC / FINRA registered broker-dealer, dedicated exclusively to serving underfollowed emerging growth companies through investment banking, wealth management, trading & execution, and equity research activities. Over the past 39 years, Noble has raised billions of dollars for companies and published more than 45,000 equity research reports. For more information, visit www.NobleCapitalMarkets.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Beatport, the global leader of music for DJs, producers and fans, and its next-generation digital marketplace, Beatport.io, has announced its newest collection: KINSHIP. The collection was created in collaboration with lifestyle and inclusivity brand HE.SHE.THEY and is a celebration of diversity and five years of HE.SHE.THEY. The collection includes 3D artist Enes Güç as well as the premiere of a brand-new documentary featuring the brand’s founders. The new digital collectible gives collectors access to the full widescreen image of the KINSHIP painting by Enes Güç as well as exclusive access to the video premiere of Beatport’s “Off the Record” documentary; additional content includes access to 2024 events hosted by HE.SHE.THEY., new music and custom cell phone/desktop wallpapers. Beatport.io is a next-generation digital marketplace bridging the gap between electronic music culture and cutting-edge technology.

The platform enables the creation and collection of unique digital projects and products that span the full spectrum of electronic music culture. “HE.SHE.THEY.’s KINSHIP collection unites the brand’s commitment to music, community and diversity, combining emotional and narrative elements into a single, cohesive product,” the announcement stated. “Founded in 2017 by Sophia Kearney and Steven Braines, HE.SHE.THEY. emerged at a time when discussions around pronouns, sexuality and inclusivity in mainstream electronic spaces were far more scarce. Now five years into their celebrated history, HE.SHE.THEY teams up with 3D artist Enes Güç for a stunning visual representation of their story thus far, with a look forward to its future.”

To view the full press release, visit https://ibn.fm/222IG

About the Beatport Group

The Beatport Group is the worldwide home of music for DJs, producers and their fans. Founded in 2004, the Beatport Group’s family of companies includes Beatport, the preeminent store for electronic music DJs; Beatsource for the open-format DJ community; Loopcloud and Plugin Boutique for music producers; ampsuite and LabelRadar for streamlining label management and demo submissions, and Beatport Media Group for brands and fans of DJ culture. Beatport Group’s portfolio of products includes an array of high-quality audio solutions to choose from, including full-song downloads, exclusive content from leading labels, a streaming music service seamlessly integrated into DJ software, and hardware, and exclusive sound packs and plugins. All of the content is expertly curated on a weekly basis by a global team that helps define DJ culture. With headquarters in LA and London, The Beatport Group’s teams reflect the culture they serve. A passionate collective of music professionals and technologists who serve the DJ and producer communities with pride. For more information about the company, please visit www.Beatport.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, has announced its unaudited financial results for the third quarter ended Sept. 30, 2023. “DoubleDown generated solid third quarter results including a nearly 19% year-over-year increase in Adjusted EBITDA to $29.7 million and $28.7 million in operating cash flow. Payer engagement remains strong… Our business model and prudent management of operating expenses continues to deliver strong Adjusted EBITDA margins, which through the first nine months of 2023 is up 530 basis points compared to the same period in 2022,” said In Keuk Kim, CEO of DoubleDown. “Our solid cash generation continues to strengthen our balance sheet as inclusive of debt, we have approximately $200 million in net cash and short-term investments even after the cash payment of approximately $36.5 million to complete the acquisition of SuprNation at the end of October. We are excited to have completed the SuprNation acquisition as it marks our entrance into the European iGaming market, which, we believe, is a high-growth gaming category that is complementary to our core operations… With this acquisition completed, we are continuing to evaluate opportunities to deploy capital to further expand our business into high-growth gaming categories with attractive addressable markets to create new value for our shareholders.”

To view the full press release, visit https://ibn.fm/Pmyca

About DoubleDown Interactive Co. Ltd.

DoubleDown Interactive is a leading developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players, bringing authentic Vegas entertainment to players around the world through an online social casino experience. Its flagship title, DoubleDown Casino, has been a fan-favorite game on leading social and mobile platforms for years, entertaining millions of players worldwide with a lineup of classic and modern games.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

FE Battery Metals (CSE: FE) (OTCQB: FEMFF) (WKN: A2JC89) has provided further details on the most recent acquisition, the Pontax West Lithium Property (“PWL”) as described in the news release dated Oct. 17, 2023. The company recently concluded a work program of prospecting, mapping and sampling with an aim to identify pegmatite targets for further exploration. In addition, FE Battery Metals announced a non-brokered private placement financing for total gross proceeds of up to $1,700,000. The financing will consist of the issuance of up to 1,250,000 common shares, each at a price of $0.40, as well as the issuance of up to 2,666,667 flow-through units at $0.45 per flow-through unit with one half of one warrant valid for two years from the date of closing. Each whole warrant will entitle the holder to purchase an additional common share for a price of $ 0.65 per share. The company intends to use proceeds from the private placement for general working capital and to further exploration efforts on its properties located in Quebec.

To view the full press release, visit https://ibn.fm/Zp2HN

About FE Battery Metals Corp.

FE Battery Metals is focused on identifying, exploring and advancing early-stage lithium pegmatite projects in Canada. The company’s primary efforts have been on exploration projects located in Quebec, with its flagship property being the Augustus Lithium Property. Augustus is located in the immediate vicinity of Val d’Or Quebec where several historical prospects and a previously active lithium mine is located within a 10km radius from the property. North American Lithium mine (“NAL”) and the Authier Project are two notable projects in the area that highlight the potential of the Augustus Lithium Property.

NOTE TO INVESTORS: The latest news and updates relating to FEMFF are available in the company’s newsroom at https://ibn.fm/FEMFF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is reporting on its Q3 2023 results, along with results from nine months for the period ended Sept. 30, 2023. Highlights of the report showed that consolidated GEO production in Q3 improved by 8% compared to both Q2 2023 and Q3 2022, with McEwen producing 38,500 GEOs in Q3 and 104,400 GEOs for the nine-month period; safety standards are being met at McEwen’s 100% owned operations with no lost-time incidents at its Fox Complex, Gold Bar Mine and El Gallo operations. Specifically, the company’s Fox Mine Complex produced 11,200 ounces gold and remains on track to meet guidance of 42,000 to 48,000 ounces gold for the year; its Gold Bar Mine produced 9,500 ounces of gold, an increase of 20% compared to Q2/23; and its San José Mine produced 17,800 GEOs, an increase of 3% compared to Q2/23 due to a modest improvement in processed tonnes. MUZ continues to advance its exploration program at Los Azules, with plans to deliver all information required for the feasibility study. The company also closed financings with Stellantis and Nuton, a Rio Tinto Venture, and is reporting consolidated cash and cash equivalents of $49.1 million and consolidated working capital of $72.3 million. Gross profit for the period came in at $3.8 million with a reported cash gross profit of $11.9 million from the company’s 100% owned precious metal operations.

To view the full press release, visit https://ibn.fm/VCoH6

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, the company owns approximately 47.7% of McEwen Copper, which owns the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. Rob McEwen, chair and chief owner, has personally provided the company with $220 million and takes an annual salary of $1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is reporting on its Q3 2023 results, along with results from nine months for the period ended Sept. 30, 2023. Highlights of the report showed that consolidated GEO production in Q3 improved by 8% compared to both Q2 2023 and Q3 2022, with McEwen producing 38,500 GEOs in Q3 and 104,400 GEOs for the nine-month period; safety standards are being met at McEwen’s 100% owned operations with no lost-time incidents at its Fox Complex, Gold Bar Mine and El Gallo operations. Specifically, the company’s Fox Mine Complex produced 11,200 ounces gold and remains on track to meet guidance of 42,000 to 48,000 ounces gold for the year; its Gold Bar Mine produced 9,500 ounces of gold, an increase of 20% compared to Q2/23; and its San José Mine produced 17,800 GEOs, an increase of 3% compared to Q2/23 due to a modest improvement in processed tonnes. MUZ continues to advance its exploration program at Los Azules, with plans to deliver all information required for the feasibility study. The company also closed financings with Stellantis and Nuton, a Rio Tinto Venture, and is reporting consolidated cash and cash equivalents of $49.1 million and consolidated working capital of $72.3 million. Gross profit for the period came in at $3.8 million with a reported cash gross profit of $11.9 million from the company’s 100% owned precious metal operations.

To view the full press release, visit https://ibn.fm/VCoH6

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, the company owns approximately 47.7% of McEwen Copper, which owns the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. Rob McEwen, chair and chief owner, has personally provided the company with $220 million and takes an annual salary of $1. To learn more about the company, visit www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at https://ibn.fm/MUX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

BlockQuarry (OTC: BLQC), a leading Texas-based energy and infrastructure company, has announced results of a favorable judgment in the case of BlockQuarry Corp v. Litchain Corp et al. According to the update, the company has reached a settlement agreement, regaining possession of mining inventory that includes pods, transformers, storage containers and miners, amongst other proceeds, from the current Gaffney, South Carolina, location. In addition to the acquisition of these assets, the company provided several forward-looking statements regarding updates on future debt consolidation and operational plans for the current mining inventory and assets on hand. “This (moment) has been a long time coming and a result in which we were confident of achieving. We have already identified next steps for both the mining equipment and settlement proceeds, which includes having our new operations management team getting to work on the equipment and reducing the company’s dilutive debt liability,” said Alozno Pierce, president and chair of BlockQuarry. “This is a very proud moment for the company and for its shareholders. We’re just getting started and I’m excited to reveal more about our upcoming operations and the expansion that is in store for the immediate future of BlockQuarry.”

To view the full press release, visit https://ibn.fm/F4IDf

About BlockQuarry Corp.

BlockQuarry is a trusted American energy and infrastructure partner, dedicated to fostering carbon-negative industrial energy and facilitating its establishment on land. It offers sustainable, renewable and cost-effective energy solutions for businesses that have a need for high-volume power, such as data warehousing, manufacturing, artificial intelligence (“AI”), and cryptocurrency mining. For more information, visit the company’s website at www.BlockQuarry.io.

NOTE TO INVESTORS: The latest news and updates relating to BLQC are available in the company’s newsroom at http://ibn.fm/BLQC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty process development and testing services to the global nutraceuticals, cosmeceuticals, food/beverage, biotherapeutics, agrochemical, and other industries has received “powerful scientific validation” through an independent peer-reviewed scientific study. According to the announcement, globally renowned cannabis/natural products researcher Dr. Mahmoud A. ElSohly, who is with ElSohly Laboratories Inc., conducted studies indicating that PBIO’s UltraShear(TM) nanoemulsified CBD, or Nano CBD, achieved “unparalleled efficiency of oral-GI CBD absorption and systemic bioavailability of active CBD.”

The company noted that ElSohly’s research verifies that PBIO’s UltraShear Technology platform allows oil-soluble active molecules, such as CBD, to be prepared into premium quality nanoemulsions of “vanishingly tiny” oil droplets in water, enabling those molecules to deliver unprecedented absorption speed and bioavailability when compared to current technologies. ElSohly’s research was published earlier this week in the “Medical Cannabis and Cannabinoids” journal. ElSohly noted that his team was surprised by the results of the oral-GI ingestion of UltraShear Nano CBD, which looked “almost like instant absorption.” PBIO’s UltraShear Nano-CBD is a preservative-free, “green/clean”-labeled, sterile-filtered and vialed, plant-based, highly bioavailable organic product. “Delivering scientifically proven breakthroughs in CBD absorption and bioavailability, UltraShear processing allows our partners to bring vastly superior products to market that give their customers more of what they are paying for,” said PBIO director of sales and marketing John Hollister in the press release. “Consumers will love the blazing fast initial benefits and the four times bioavailability that deliver a dramatically improved consumer experience.”

To view the full press release, visit https://ibn.fm/pgqfH

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high-pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical and agrochemical, as well as food and beverage manufacturing. The company’s products utilize both constant and alternating pressure. PBIO’s first patented enabling technology platform, Pressure Cycling Technology (“PCT”), is used to control biomolecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics and counterbioterrorism applications. The company’s acquisition of the BaroFold(TM) patented technology platform in 2017 allowed it to offer important new biopharma contract services and GMP manufacturing equipment to this enormous market sector. Most recently, the company has also developed the commercially scalable and high-efficiency pressure-based UltraShear Technology(TM) platform, which allows for the production of stable and precisely controlled nanoemulsions of otherwise immiscible oil and water components. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room-temperature-stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. The company’s commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to its customers. For more information, visit the company website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Flora (NASDAQ: FLGC), a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, has announced its financial and operating results for the three and nine months ended Sept. 30, 2023. “The third quarter was a record quarter for Flora. Our efforts to cut costs, divest unprofitable operations and focus on growing segments have begun to pay off. For the first time in the company’s history, Flora delivered a profitable, EBITDA-positive and operating cashflow-positive quarter. Further, Flora has a liquidity position that includes cash of $4.8 million and net working capital of $7.3 million,” Flora’s CEO Clifford Starke said of the results. “The business transformation has been productive, and we have achieved our short-term goals. Now we will focus on execution and growing the businesses for scale and profitability.”

To view the full press release, visit https://ibn.fm/FAnkP

About Flora Growth Corp.

Flora is a global consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world. For more information on Flora, visit www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Processa Pharmaceuticals (NASDAQ: PCSA) is a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer. The company today announced that its president of research and development, Dr. David Young, will present at the 20th Orphan Drugs and Rare Diseases Global Congress 2023 Americas and will be available for one-on-one meetings throughout the conference. The event is slated to take place at the Revere Hotel Boston Common in Boston, Massachusetts, Nov. 16 – 17, 2023. Dr. Young’s presentation is scheduled to begin at 2:40 p.m. ET on Thursday, Nov. 16.

To view the full press release, visit https://ibn.fm/N6iZy

About Processa Pharmaceuticals Inc.

Processa is a clinical stage pharmaceutical company focused on developing the Next Generation Chemotherapy drugs to improve the safety and efficacy of cancer treatment. By combining Processa’s novel oncology pipeline with proven cancer-killing active molecules and the Processa Regulatory Science Approach as well as experience in defining Optimal Dosage Regimens for FDA approvals, Processa not only will be providing better therapy options to cancer patients but also increase the probability of FDA approval for its Next Generation Chemotherapy drugs. Processa’s NGC drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells. Its approach to drug development is based on more than 30 years of drug development expertise to efficiently design and conduct clinical trials that demonstrate a positive benefit/risk relationship. Using its proven Regulatory Science Approach, Processa has experience defining the Optimal Dosage Regimen using the principles of the FDA’s Project Optimus Oncology initiative. The advantages of Processa’s Next Generation Chemotherapy drugs are expected to include fewer patients experiencing side effects that lead to dose discontinuation; more significant cancer response; and a greater number of patients who will benefit from each Next Generation Chemotherapy drug. Currently in its pipeline are three Next Generation Chemotherapy drugs: Next Generation Capecitabine (“PCS6422” and capecitabine to treat metastatic colorectal, gastrointestinal, breast, pancreatic, and other cancers), Next Generation Gemcitabine (“PCS3117” to treat pancreatic, lung, ovarian, breast, and other cancers), and Next Generation Irinotecan (“PCS11T” to treat lung, colorectal, gastrointestinal, pancreatic, and other cancers). For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, has launched into a new U.S. market: Ohio. The expansion, which follows the state’s successful voting in support of the legalization of adult-use marijuana, was made as the company inked a licensing arrangement with a first-mover, vertically integrated Ohio distributor. This partnership allows RWB to leverage the distributor’s existing retail network to introduce its well-known Platinum Vape cartridges and disposable vapes; RWB’s products are now available in various formats and across more than 90 licensed retail locations in the state. Earlier this week, voters in the state approved an adult-use marijuana legalization ballot, marking a milestone for the state and positioning Ohio as the 24th state to adopt progressive cannabis reform. Adult-use sales in Ohio have been forecast to reach an estimated $1.5 billion to $2 billion in the first year.

The company noted that the launch of its Platinum brand of vape products in Ohio aligns seamlessly with the state’s evolving cannabis landscape. “RWB takes great pride in expanding its presence in emerging adult-use markets in the United States,” said Red White & Bloom president Colby De Zen in the press release. “Ohio represents another pivotal entry point for RWB, allowing us to leverage the continually strengthening brand equity of Platinum, which has consistently excelled in the vape categories in neighboring Michigan. RWB remains focused on ensuring that each of its expansion efforts are reinforced by well-established licensing partners who recognize the value of premium Platinum cannabis products. These partners contribute to enhancing the consumer experience and also possess the commercial capacity to meet the growing demand for our esteemed Platinum product line, supported by RWB’s targeted marketing efforts.”

To view the full press release, visit https://ibn.fm/PSXKu

About Red White & Bloom Brands Inc.

Red White & Bloom is a multistate cannabis operator and house of premium brands in the U.S. legal cannabis sector. RWB is predominantly focusing its investments on the major U.S. markets, including Arizona, California, Florida, Massachusetts, Missouri, Michigan and Ohio, as well as targeted Canadian markets. For more information about the company, please visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Tingo Group (NASDAQ: TIO), a profitable, multi-national fintech, agri-fintech, food processing and commodity trading company, today announced that it will hold a conference call to present its results for the third quarter ended Sept. 30, 2023, and provide a business update. The call is scheduled to begin at 8:00 a.m. Eastern Time on Tuesday Nov. 14, 2023, and will be accompanied by a presentation that can be viewed during the webcast or accessed via the investor relations section of the company’s website. Interested parties should visit https://ibn.fm/wLMS7 to register for and access the webcast and dial 1-844-826-3035 or 1-412-317-5195 (international) and enter conference code 10184362 to access the call. A telephone replay will be available approximately three hours after the call as detailed in the announcement.

To view the full press release, visit https://ibn.fm/N0JqF

About Tingo Group Inc.

Tingo is a global fintech, agri-fintech, food processing and commodity trading group of companies with operations in Africa, Southeast Asia and the Middle East. Tingo Group’s wholly owned subsidiary, Tingo Mobile, is a leading agri-fintech company operating in Africa, with a comprehensive portfolio of innovative products, including a “device-as-a-service” smartphone and a value-added service platform, the cornerstone of which is the Nwassa “seed-to-sale” marketplace platform, as well as insurance, micro-finance and mobile phone and data top-up. Tingo Group’s other business verticals include: TingoPay, a super app in partnership with Visa, offering a wide range of B2C and B2B services including payment services, an e-wallet, foreign exchange and merchant services; Tingo Foods, a food processing business that processes raw foods into finished products such as rice, groundnut oil, nut products, wheat, millet and maize; and Tingo DMCC, a commodity trading platform and agricultural commodities export business based out of the Dubai Multi Commodities Center. In addition to its Tingo business verticals, Tingo Group also holds and operates an insurance brokerage platform business in China; and Magpie Securities, a regulated finance services fintech business operating out of Hong Kong and Singapore, which, as relatively small businesses within the company, are currently in the process of being reviewed and re-positioned. For more information about the company, visit www.TingoGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to TIO are available in the company’s newsroom at https://ibn.fm/TIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Leading industry academics, practitioners, and engineers, will gather at the QuantMinds International  2023 conference in London from November 13-16, 2023. They will discuss and share in-depth insights into the latest trends and cutting-edge technologies in quant finance for better scope in their future endeavours. Over 500 industry practitioners and academics, 110+ asset managers, and 8 out of the 10 top banks of Europe are expected to grace the event.

On the opening day of the summit on November 13, 2023, numerous workshops and interactive sessions will be held as follows…

Read More>>

To know more, please visit https://ibn.fm/wrCOn.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Predictive Oncology (NASDAQ: POAI), a leader in artificial intelligence (“AI”)-driven drug discovery and biologics, has completed a multiyear study through a partnership with UPMC Magee-Womens Hospital. The study was focused on evaluating the use of AI in building multiomic machine learning (“ML”) models and then testing the models to determine if they could learn associations between datasets and ovarian cancer patient short- and long-term survival. According to the press release, the study used one of the largest sets of multiomic data, which included data from 235 ovarian cancer patients, to identify key features impacting overall survival endpoints. That data was then used to create strong predictive models with high levels of accuracy that have the potential to become invaluable clinical support tools. Company officials noted that high-grade serious carcinomas of the ovary make up the majority of ovarian cancer cases and also have the lowest survival rates. “Ultimately, these models could support the tailoring of therapies to individual patients with the goal of positively affecting the overall survival of ovarian cancer patients,” said Predictive Oncology CEO Raymond F. Vennare in the press release. “These findings were only made possible because of the substantial resources at our disposal, including a robust machine-learning platform, the use of digital pathology, access to an extensive biobank of cryopreserved tumor samples and our considerable scientific expertise.”

To view the full press release, visit https://ibn.fm/RyM17

About Predictive Oncology Inc.

Predictive Oncology is on the cutting edge of the rapidly growing use of artificial intelligence (“AI”) and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients worldwide. The company’s scientifically validated AI platform, PEDAL, is able to predict with 92% accuracy if a tumor sample will respond to a certain drug compound, allowing for a more informed selection of drug/tumor type combinations for subsequent in-vitro testing. With the company’s vast biobank of more than 150,000 assay-capable heterogenous human tumor samples, Predictive Oncology offers its academic and industry partners one of the industry’s broadest AI-based, drug-discovery solutions, further complemented by its wholly owned CLIA lab and GMP facilities. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced plans to initiate a dose-ranging study of its targeted prophylactic treatment SPC-15 for the treatment of post-traumatic stress disorder (“PTSD”). The six- to eight-week non-good laboratory practice (“GLP”) study will identify the maximum tolerated intranasal dose of the drug and pharmacokinetic in small animals to determine the therapeutically relevant dose range. In collaboration with AmplifyBio, Silo Pharma’s contract research organization (“CRO”) partner, the study will include a phase 1 single ascending dose evaluation and a seven-day repeat intranasal dose toxicity and pharmacokinetic study. “Determining the dose range that should be studied is an important step before taking a new drug candidate into a first-in-human trial,” said Eric Weisblum, chief executive officer of Silo Pharma. “Completion of this study, along with our recently announced human factor study, is expected to give us an early start on our goal of a phase 1 clinical trial of SPC-15.”

To view the full press release, visit https://ibn.fm/XyawR

About Silo Pharma Inc.

Silo Pharma is a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer’s disease and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research, which it believes will be transformative to the well-being of patients and the health care industry. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, is announcing additional contracts as the company sees significant success in its efforts to help protect the places people live, work, study and visit. According to the announcement, Knightscope has signed two contracts for its K5 autonomous security robots.

KSCP has added to its client list a commercial real estate property — a corporate campus property in North Hollywood, California. The contract, which calls for Knightscope to deploy a K5 ASR to patrol the campus, is with an American commercial real estate services and investment firm that has been a national account target since 2017.

“The client manages a property occupied by one of the world’s largest multinational telecommunications companies, coincidentally another major account target since 2017, making this a particularly attractive ‘double win’ for Knightscope that opens the door to future U.S. expansions,” stated the company in the press release.

The second contract is for a casino expansion in Lake Charles, Louisiana. The deal is part of a master contract announced earlier this year outlining the deployment of Knightscope technologies at 43 properties nationwide. The contract calls for Knightscope ASRs to protect and engage the millions of people who visit these sites by greeting guests while also providing additional eyes and ears to the human security team, including a two-way communication system to enhance the safety of visitors and workers.

“One of the best ways to gauge the overall health and performance of a company is by watching its existing clients — especially those that broaden the use of one’s products and services,” stated the company in the press release. “The benefits of such expansions include shorter sales cycles and higher, more efficient close rates. Today’s announcement brings the total robots under contract for this gaming client to seven, which include deployments in Las Vegas, Nevada; Council Bluffs, Iowa; Aurora, Illinois; Shreveport, Louisiana; Bossier City, Louisiana; and New Orleans, Louisiana.”

To view the full press release, visit https://ibn.fm/dklty

About Knightscope, Inc.

Knightscope is an advanced public safety technology company that builds fully autonomous security robots and blue light emergency communications systems that help protect the places people live, work, study and visit. Knightscope’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN